Early Dynamics and Depth of Response in Multiple Myeloma Patients Treated With BCMA CAR-T Cells

Early Dynamics and Depth of Response in Multiple Myeloma Patients Treated With BCMA CAR-T Cells

Chimeric antigen receptor T-cell (CAR-T) therapy targeted against B-cell maturation antigen (BCMA) in multiple myeloma (MM) has produced rapid responses but many eventually relapse. In light of this new treatment, novel predictors of progression-free survival (PFS) are needed. We performed a single...

Full description

Bibliographic Details
Main Authors: Sandy W. Wong, Nina Shah, Guy Ledergor, Thomas Martin, Jeffrey Wolf, Amy M. Shui, Chiung-Yu Huang, Joaquin Martinez-Lopez
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Oncology
Subjects:
multiple myeloma
CAR-T
minimal residual disease
sFLC
PET-CT
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.783703/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.783703/full

Similar Items